Citation 155678

YE,WY: LI,MZ: GIAN,ZK:. (1979). SOL. "ANTINFLAMMATIO NO. 6" PRO INJECTIONE.. 8()

Citation Details

Title	SOL. "ANTINFLAMMATIO NO. 6" PRO INJECTIONE.
Authors	YE,WY: LI,MZ: GIAN,ZK:
Year	1979
Volume	8
Issue

Summary

Year: 1979

Journal: Unknown

Organisms and Their Experiments (4)

Taraxacum mongolicum (ASTERACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ANTIBACTERIAL ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	None	ACTIVE
2	ANTIBACTERIAL ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	None	ACTIVE
3	ANTIBACTERIAL ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	None	ACTIVE
4	ANTIBACTERIAL ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVOANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	None	ACTIVE
5	ANTIINFLAMMATORY ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
6	ANTIINFLAMMATORY ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
7	ANTIPYRETIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
8	CAPILLARY PERMEABILITY DECREASED	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
9	PHAGOCYTOSIS STIMULATION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
10	ALLERGENIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
11	HEMOLYTIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITRO	None	INACTIVE
12	ANTIBACTERIAL ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN HUMANSTRADITIONAL MEDICINEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	None	ACTIVE
13	ANTIBACTERIAL ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN HUMANSTRADITIONAL MEDICINEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	None	ACTIVE
14	ANTIBACTERIAL ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN HUMANSTRADITIONAL MEDICINEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	None	ACTIVE
15	ANTIBACTERIAL ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN HUMANSTRADITIONAL MEDICINEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	None	ACTIVE
16	ANTIINFLAMMATORY ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN HUMANSTRADITIONAL MEDICINE	None	ACTIVE
17	ANTIINFLAMMATORY ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN HUMANSTRADITIONAL MEDICINE	None	ACTIVE
18	ANTIVIRAL ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN HUMANSTRADITIONAL MEDICINEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	None	ACTIVE
19	ANTIVIRAL ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN HUMANSTRADITIONAL MEDICINEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	None	ACTIVE

Clerodendrum cyrtophyllum (VERBENACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ANTIBACTERIAL ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	None	ACTIVE
2	ANTIBACTERIAL ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	None	ACTIVE
3	ANTIBACTERIAL ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	None	ACTIVE
4	ANTIBACTERIAL ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVOANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	None	ACTIVE
5	ANTIINFLAMMATORY ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
6	ANTIINFLAMMATORY ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
7	ANTIPYRETIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
8	CAPILLARY PERMEABILITY DECREASED	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
9	PHAGOCYTOSIS STIMULATION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
10	ALLERGENIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
11	HEMOLYTIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITRO	None	INACTIVE
12	ANTIBACTERIAL ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN HUMANSTRADITIONAL MEDICINEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	None	ACTIVE
13	ANTIBACTERIAL ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN HUMANSTRADITIONAL MEDICINEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	None	ACTIVE
14	ANTIBACTERIAL ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN HUMANSTRADITIONAL MEDICINEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	None	ACTIVE
15	ANTIBACTERIAL ACTIVITY	PHARMACOLOGY OF EXTRACT - IN HUMANSTRADITIONAL MEDICINEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	None	ACTIVE
16	ANTIINFLAMMATORY ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN HUMANSTRADITIONAL MEDICINE	None	ACTIVE
17	ANTIINFLAMMATORY ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN HUMANSTRADITIONAL MEDICINE	None	ACTIVE
18	ANTIVIRAL ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN HUMANSTRADITIONAL MEDICINEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	None	ACTIVE
19	ANTIVIRAL ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN HUMANSTRADITIONAL MEDICINEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	None	ACTIVE

Lonicera japonica (CAPRIFOLIACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ANTIBACTERIAL ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	None	ACTIVE
2	ANTIBACTERIAL ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	None	ACTIVE
3	ANTIBACTERIAL ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	None	ACTIVE
4	ANTIBACTERIAL ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVOANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	None	ACTIVE
5	ANTIINFLAMMATORY ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
6	ANTIINFLAMMATORY ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
7	ANTIPYRETIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
8	CAPILLARY PERMEABILITY DECREASED	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
9	PHAGOCYTOSIS STIMULATION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
10	ALLERGENIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
11	HEMOLYTIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITRO	None	INACTIVE
12	ANTIBACTERIAL ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN HUMANSTRADITIONAL MEDICINEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	None	ACTIVE
13	ANTIBACTERIAL ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN HUMANSTRADITIONAL MEDICINEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	None	ACTIVE
14	ANTIBACTERIAL ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN HUMANSTRADITIONAL MEDICINEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	None	ACTIVE
15	ANTIBACTERIAL ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN HUMANSTRADITIONAL MEDICINEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	None	ACTIVE
16	ANTIINFLAMMATORY ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN HUMANSTRADITIONAL MEDICINE	None	ACTIVE
17	ANTIINFLAMMATORY ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN HUMANSTRADITIONAL MEDICINE	None	ACTIVE
18	ANTIVIRAL ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN HUMANSTRADITIONAL MEDICINEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	None	ACTIVE
19	ANTIVIRAL ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN HUMANSTRADITIONAL MEDICINEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	None	ACTIVE

Houttuynia cordata (SAURURACEAE)

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ANTIBACTERIAL ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	None	ACTIVE
2	ANTIBACTERIAL ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	None	ACTIVE
3	ANTIBACTERIAL ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	None	ACTIVE
4	ANTIBACTERIAL ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVOANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	None	ACTIVE
5	ANTIINFLAMMATORY ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
6	ANTIINFLAMMATORY ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
7	ANTIPYRETIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
8	CAPILLARY PERMEABILITY DECREASED	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
9	PHAGOCYTOSIS STIMULATION	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	ACTIVE
10	ALLERGENIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VIVO	None	INACTIVE
11	HEMOLYTIC ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN VITRO	None	INACTIVE
12	ANTIBACTERIAL ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN HUMANSTRADITIONAL MEDICINEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	None	ACTIVE
13	ANTIBACTERIAL ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN HUMANSTRADITIONAL MEDICINEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	None	ACTIVE
14	ANTIBACTERIAL ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN HUMANSTRADITIONAL MEDICINEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	None	ACTIVE
15	ANTIBACTERIAL ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN HUMANSTRADITIONAL MEDICINEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	None	ACTIVE
16	ANTIINFLAMMATORY ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN HUMANSTRADITIONAL MEDICINE	None	ACTIVE
17	ANTIINFLAMMATORY ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN HUMANSTRADITIONAL MEDICINE	None	ACTIVE
18	ANTIVIRAL ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN HUMANSTRADITIONAL MEDICINEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	None	ACTIVE
19	ANTIVIRAL ACTIVITY	EFFECTS DUE TO A COMBINATION OF DRUGSPHARMACOLOGY OF EXTRACT - IN HUMANSTRADITIONAL MEDICINEANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	None	ACTIVE

Show SPARQL Queries (1)